TD Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.82M Buy
2025
Q1
$5.86M Sell
2024
Q4
$11.7M Buy
2024
Q3
$10.7M Buy
2024
Q2
$9.18M Sell
2024
Q1
$11M Buy
2023
Q4
$6.28M Buy
2023
Q3
$4.15M Buy
2023
Q2
$1.06M Buy
2023
Q1
$443K Buy
2019
Q3
Sell
2019
Q2
$210K Buy
2019
Q1
Sell
2018
Q4
$288K Sell
2018
Q3
$313K Buy